Hamel Lawrence G

Avg. Two Year Performance

No purchase track record
61% Avg. Sale Return
27% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return41%56%44%43%61%
Sale Success Rate2 of 22 of 22 of 22 of 22 of 2
Drugs » Drug Manufacturers - Major

Chief Development Officer:

Holdings: 157.56K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--